Heliyon (Oct 2023)

Clinical and molecular analysis of Guangxi patients with Kabuki syndrome and KMT2D mutations

  • Sheng Yi,
  • Xiaofei Zhang,
  • Qi Yang,
  • Jingjing Huang,
  • Xunzhao Zhou,
  • Jiale Qian,
  • Pingshan Pan,
  • Shang Yi,
  • Shujie Zhang,
  • Qiang Zhang,
  • Xianglian Tang,
  • Limei Huang,
  • Qinle Zhang,
  • Zailong Qin,
  • Jingsi Luo

Journal volume & issue
Vol. 9, no. 10
p. e20223

Abstract

Read online

Kabuki syndrome (KS) is a multiple congenital anomaly syndrome that is characterized by postnatal growth deficiency, hypotonia, short stature, mild-to-moderate intellectual disability, skeletal abnormalities, persistence of fetal fingertip pads, and distinct facial appearance. It is mainly caused by pathogenic/likely pathogenic variants in the KMT2D or KDM6A genes. Here, we described the clinical features of nine sporadic KS patients with considerable phenotypic heterogeneity. In addition to intellectual disability and short stature, our patients presented with a high prevalence of motor retardation and recurrent otitis media. We recommended that KS should be strongly considered in patients with motor delay, short stature, intellectual disability, language disorder and facial deformities. Nine KMT2D variants, four of which were novel, were identified by whole-exome sequencing. The variants included five nonsense variants, two frameshift variants, one missense variant, and one non-canonical splice site variant. In addition, we reviewed the mutation types of the pathogenic KMT2D variants in the ClinVar database. We also indicated that effective mRNA analysis, using biological materials from patients, is helpful in classifying the pathogenicity of atypical splice site variants. Pedigree segregation analysis may also provide valuable information for pathogenicity classification of novel missense variants. These findings extended the mutation spectrum of KMT2D and provided new insights into the understanding of genotype-phenotype correlations, which are helpful for accurate genetic counseling and treatment optimization.

Keywords